PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients
The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.
UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics
“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman.
Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer
One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.
Some PET exams may be overutilized in oncology
In 2020 alone, there were more than 2 million 18F-FDG PET/CT scans conducted in the United States.
PSMA-PET imaging not the most cost-effective option for many prostate cancer patients
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.

merger acquisition handshake deal business agreement partnership

Siemens Healthineers inks data sharing deal with Blue Earth to bolster development of prostate cancer AI

Blue Earth will be sharing anonymized clinical data from its Phase 3 Lighthouse trial involving the use of PET imaging agent Posluma.

Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration.

New PET agent offers 'exceptional' imaging of kidney cancer

The agent was found to be better than standard CT imaging for patients with clear cell renal cell cancer.

New PET technique spots 'smoldering' changes not visible on MRI in the brains of MS patients

The new technique uncovers hidden inflammation in patients who, despite undergoing extensive treatment for the condition, had worsening symptoms.

Imaging agent that targets deadly brain tumors given FDA's Fast Track designation

Fast Track designations are typically granted to drugs that target an unmet medical need.

PET/MRI may reduce unnecessary prostate biopsies by 83%

A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.

RLS Radiopharmacies purchases Gallium-68 generators for all its locations

The supply agreement with Eckert & Ziegler will ensure radiopharmaceuticals are available for PET imaging and cancer treatment plans.

UC San Diego earns $6.7M NIH grant to develop noninvasive imaging to quantify immune cells in tumors

The TAM-Sense technique is currently in pre-clinical development, but it could be used to develop new treatments.

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

PET/CT

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics

Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer

Some PET exams may be overutilized in oncology

PSMA-PET imaging not the most cost-effective option for many prostate cancer patients